Clinical Trial Update: Paricalcitol and Endothelial Function in Chronic Kidney Disease Patients (the PENNY Study) [Phase 3]

View source ↗

Summary

A Phase 3 trial (the PENNY study) evaluating paricalcitol for improving endothelial function in patients with chronic kidney disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Paricalcitol (paricalcitol)

Snippet

Sponsor: Fondazione C.N.R./Regione Toscana "G. Monasterio", Pisa, Italy | Conditions: Chronic Kidney Disease. | Phase 3 | Status: COMPLETED